* Ultralife Corp ULBI.OQ reported quarterly adjusted earnings
of 4 cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for earnings of 6 cents per
share.
* Revenue was $25.97 million; analysts expected $26.70
million.
* Ultralife Corp's reported EPS for the quarter was 4 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Ultralife Corp shares had fallen by 3.3% this quarter and
gained 23.8% so far this year.
* The company reported quarterly net income of $671 thousand.
* Wall Street's median 12-month price target for Ultralife Corp
is $12.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated April 29 at 06:16 p.m. GMT.
All figures in US Dollars.